BHVN
NYSE · Biotechnology
Biohaven Ltd
$8.39
-0.35 (-4.00%)
Analyst Consensus
Strong Buy
24
Analysts
High
Coverage
Price Target
Analyst Price Target
+258.3% upside
Low Target
$17.22
Average Target
$30.06
High Target
$35.82
Current Price
$8.39
Current
$8.39
$8.39
Target
$30.06
$30.06
$17.22
$30.06 avg
$35.82
Scenario Analysis
Bear Case
$17.22
105.2%
Low target
Base Case
$30.06
+258.3%
Avg target
Bull Case
$35.82
+326.9%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$40.82
-79.4% from high
52-Week Low
$7.48
+12.2% from low
Target vs 52W High
$30.06
-26.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |